OraSure Technologies, Inc.

NASDAQ:OSUR

4.3 (USD) • At close July 12, 2024
Bedrijfsnaam OraSure Technologies, Inc.
Symbool OSUR
Munteenheid USD
Prijs 4.3
Beurswaarde 318,024,990
Dividendpercentage 0%
52-weken bereik 3.92 - 8.45
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Ms. Carrie Eglinton Manner
Website https://www.orasure.com

An error occurred while fetching data.

Over OraSure Technologies, Inc.

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro,

Vergelijkbare Aandelen

EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc.

EYPT

10.33 USD

C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

CCCC

5.65 USD

ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

ALXO

7.06 USD

Absci Corporation logo

Absci Corporation

ABSI

4.03 USD

HilleVax, Inc. logo

HilleVax, Inc.

HLVX

1.75 USD

Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc.

HRTX

3.24 USD

Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc.

ANIK

27.13 USD

BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

BTAI

1.21 USD

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

8.01 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)